´
A. Klasek et al. / Tetrahedron 60 (2004) 9953–9961
9960
(0.631 g, 6 mmol) in aqueous dioxane (70%, 10 mL) was
stirred at 100 8C for the time given in Table 3. The work up
of the reaction mixture was carried out in the same way as in
Method A.
763, 712, 658, 613, 540 cmK1. Positive-ion APCI-MS: m/z
366 [MCH]C (100%), 348 [MCH–H2O]C, 323 [MCH–
NHCO]C. Positive-ion APCI-MS/MS of m/z 366: 323
[MCH–NHCO]C, 233 [MCH–C6H5CH2NCO]C (100%),
216 [MCH–C6H5CH2NCO–NH3]C, 177 [MCH–C6H5-
CH2NCO-butene]C, 146. Negative-ion APCI-MS: 364
[MKH]K (100%), 346 [MKH–H2O]K, 316 [MKH–
H2O–HCHO]K, 255, 161. Negative-ion APCI-MS/MS of
m/z 364: 346 [MKH–H2O]K, 321 [MKH–NHCO]K
(100%), 229 [MKH–NHCO–C6H5CH3]K, 216 [MKH–
NHCO–C6H5–CO]K. Anal. Calcd (found) for C21H23N3O3:
C 69.02 (69.15); H 6.34 (6.09); N 11.50 (11.33).
3.2.1. 3-Butyl-3-ureido-1H,3H-quinoline-2,4-dione (11a).
Yield 50% (Method A, 90 min). Colourless crystals, mp
220–224 8C, IR: 3408, 3335, 3236, 3092, 2960, 2930, 2871,
1712, 1666, 1613, 1548, 1523, 1486, 1433, 1365, 1256,
1192, 1116, 951, 940, 775, 753, 668, 623, 548, 529 cmK1
.
Positive-ion APCI-MS: m/z 276 [MCH]C, 233 [MCH–
NHCO]C (100%), 215 [MCH–NHCO–H2O]C, 188 [MC
H–NHCO–NH2CHO]C, 177 [MCH–NHCO-butene]C.
Positive-ion APCI-MS/MS of m/z 276: 259 [MCH–
NH3]C, 233 [MCH–NHCO]C (100%), 215 [MCH–
NHCO–H2O]C. Negative-ion APCI-MS: 274 [MKH]K
(100%), 231 [MKH–NHCO]K, 161 [C6H4NHCOCH2-
CO]K, 146 [C6H4(CO)NCO]K. Negative-ion APCI-MS/
MS of m/z 274: 256 [MKH–H2O]K, 231 [MKH–NHCO]K
(100%), 213 [MKH–NHCO–H2O]K. Anal. Calcd (found)
for C14H17N3O3: C 61.08 (60.88); H 6.22 (6.35); N 15.26
(15.03).
3.2.5. 3-Butyl-9b-hydroxy-3a-phenyl-3,3a,5,9b-tetra-
hydro-1H-imidazo[4,5-c]quinoline-2,4-dione (12e).
Yield 52% (Method A, 5.5 h). Colourless crystals, mp
174–183 8C and 294–297 8C (2-propanol), IR: 3411, 3334,
3195, 3066, 2957, 2928, 1705, 1678, 1599, 1496, 1446,
1413, 1371, 1217, 1135, 1071, 952, 865, 762, 751, 701, 680,
656, 633, 597 cmK1. Positive-ion APCI-MS: m/z 352 [MC
H]C, 334 [MCH–H2O]C (100%), 309 [MCH–NHCO]C.
Positive-ion APCI-MS/MS of m/z 352: 309 [MCH–
NHCO]C (100%). Negative-ion APCI-MS: 350 [MKH]K,
332 [MKH–H2O]K (100%), 306 [MKH–NH2CO]K, 249
[MKH–NH2CHO-butene]K. Negative-ion APCI-MS/MS of
m/z 350: 332 [MKH–H2O]K, 306 [MKH–NHCO]K (100%),
293 [MKH-butyl]K, 275 [MKH–H2O-butyl]K, 249 [MKH–
NH2CHO-butene]K. Anal. Calcd (found) for C20H21N3O3: C
68.36 (68.51); H 6.02 (6.23); N 11.96 (11.71).
3.2.2. 9b-Hydroxy-3a-phenyl-3,3a,5,9b-tetrahydro-1H-
imidazo[4,5-c]quinoline-2,4-dione (12b). Yield 57%
(Method A, 150 min) or 58% (Method B, 135 min).
Colourless crystals, mp 269–274 8C (methanol), IR: 3365,
3262, 3195, 3078, 2991, 2919, 1712, 1690, 1617, 1598,
1494, 1441, 1402, 1231, 1058, 998, 894, 880, 848, 763, 700,
649, 602, 570 cmK1. Positive-ion APCI-MS: m/z 296 [MC
H]C, 278 [MCH–H2O]C, 253 [MCH–NHCO]C (100%),
236 [MCH–NH2CONH2]C, 223 [MCH–NHCO–
HCHO]C, 208 [MCH–NH2CONH2–CO]C. Positive-ion
APCI MS/MS of m/z 296: 278 [MCH–H2O]C, 253 [MC
H–NHCO]C (100%), 236 [MCH–NH2CONH2]C. Nega-
tive-ion APCI-MS and MS/MS of m/z 294 are the same: 294
[MKH]K (100% for MS), 276 [MKH–H2O]K, 251 [MK
H–NHCO]K, 233 [MKH–NHCO–H2O]K (100% for MS/
MS), 207, 161. Anal. Calcd (found) for C16H13N3O3: C
65.08 (64.83); H 4.44 (4.65); N 14.23 (14.09).
3.2.6. 3-Benzyl-9b-hydroxy-3a-phenyl-3,3a,5,9b-tetra-
hydro-1H-imidazo[4,5-c]quinoline-2,4-dione (12f). Yield
30% (Method A, 6 h) or 16% (Method B, 5.5 h). Colourless
crystals, mp 186–196 8C (ethanol), IR: 3384, 3351, 3198,
3095, 2907, 1712, 1675, 1597, 1485, 1434, 1399, 1368,
1349, 1231, 1125, 1078, 934, 896, 802, 773, 747, 717, 697,
671, 655, 607, 593, 576 cmK1. Positive-ion APCI-MS: m/z
386 [MCH]C (100%), 368 [MCH–H2O]C, 343 [MCH–
NHCO]C, 253 [MCH–C6H5CH2NCO]C. Positive-ion
APCI-MS/MS of m/z 386: 343 [MCH–NHCO]C (100%),
278, 253 [MCH–C6H5CH2NCO]C, 236 [MCH–C6H5-
CH2NCO–NH3]C, 208 [MCH–C6H5CH2NCO–NH3–
CO]C. Negative-ion APCI-MS and MS/MS of m/z 384 are
the same: 384 [MKH]K (100% for MS), 366 [MKH–
H2O]K, 340 [MKH–NH2CO]K, 275 [MKH–H2O–
C6H5CH2]K (100% for MS/MS), 249, 236. Anal. Calcd
(found) for C23H19N3O3: C 71.67 (71.45); H 4.97 (5.21); N
10.90 (10.69).
3.2.3. 3,3a-Dibutyl-9b-hydroxy-3,3a,5,9b-tetrahydro-
1H-imidazo[4,5-c]quinoline-2,4-dione (12c). Yield 49%
(Method A, 4 h). Colourless crystals, mp 170–176 8C and
281–285 8C (ethyl acetate), IR: 3384, 3263, 3202, 3067,
2958, 2932, 2870, 1696, 1677, 1601, 1496, 1466, 1432,
1384, 1245, 1122, 1063, 849, 755, 658, 625, 543, 524 cmK1
.
Positive-ion APCI-MS: m/z 332 [MCH]C (100%), 314
[MCH–H2O]C, 289 [MCH–NHCO]C. Positive-ion APCI-
MS/MS of m/z 332: 289 [MCH–NHCO]C (100%).
Negative-ion APCI-MS: 330 [MKH]K (100%), 312 [MK
H–H2O]K, 269 [MKH–H2O–NHCO]K, 255 [MKH–H2O-
butyl]K. Negative-ion APCI-MS/MS of m/z 330: 312
[MKH–H2O]K, 287 [MKH–NHCO]K, 230 [MKH–
NHCO-butyl]K. Anal. Calcd (found) for C18H25N3O3: C
65.23 (65.12); H 7.60 (7.42); N 12.68 (12.73).
3.3. General procedure for the preparation of 3,3a-
dihydro-5H-imidazo[4,5-c]quinoline-2,4-diones (13c–f)
To the stirred suspension of compound 12c–f (0.5 mmol) in
chloroform (25 mL), powdered phosphorus pentoxide
(107 mg, 0.75 mmol) was added in one portion at rt. After
10 min, the mixture was filtrated through a column filled
with silica gel (7.5 g). Column was washed with chloroform
(250 mL), collected filtrates were evaporated to dryness in
vacuo and the residue was crystallized from benzene or
benzene–hexane.
3.2.4. 3-Benzyl-3a-butyl-9b-hydroxy-3,3a,5,9b-tetra-
hydro-1H-imidazo[4,5-c]quinoline-2,4-dione (12d).
Yield 35% (Method A, 15 h). Colourless crystals, mp
178–187 8C and 280–283 8C (ethyl acetate), IR: 3368, 3349,
3199, 3098, 2962, 2930, 2868, 1710, 1664, 1598, 1486,
1441, 1416, 1384, 1229, 1123, 1061, 947, 886, 800, 773,
3.3.1. 3,3a-Dibutyl-3,3a-dihydro-5H-imidazo[4,5-c]-
quinoline-2,4-dione (13c). Yield 87%. Colourless crystals,